Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Denny Bros restructures Board of Directors
Denny Bros restructures Board of Directors
Barry Denny becomes Chairman, while Graham Denny steps up to Managing Director
Endo announces changes to senior management team
Endo announces changes to senior management team
To accelerate growth both organically and through corporate development activities
Ken Dickerson joins BiOptix as Vice President of Sales
Ken Dickerson joins BiOptix as Vice President of Sales
Brings 20 years of experiences in sales to his new position
Vaccinogen names Peter Morsing as Head of Business Development
Vaccinogen names Peter Morsing as Head of Business Development
Industry veteran brings nearly 20 years of pharmaceutical development and licensing experience to the company
Cytovance Biologics appoints Director of Purification Development
Cytovance Biologics appoints Director of Purification Development
Seth Fisher joins the team in Oklahoma City, US
CiToxLAB hires Senior Director of Biomarkers
CiToxLAB hires Senior Director of Biomarkers
Philippe Ancian returns to the French contract research organisation
Marken appoints General Manager for Argentina and Brazil
Marken appoints General Manager for Argentina and Brazil
Antonio Beloto will lead logistical operations in both countries
Hovione promotes Filipe Gaspar to Vice President of Research & Development
Hovione promotes Filipe Gaspar to Vice President of Research & Development
He joined the Portuguese company in 2003
Associate Partner joins Alacrita in Cambridge, MA, US
Associate Partner joins Alacrita in Cambridge, MA, US
William Slichenmyer will advise on clinical development strategy, planning and operations
New Chief Innovation Officer at Evonik
New Chief Innovation Officer at Evonik
Ulrich Kuesthardt succeeds Peter Nagler
Rx-360 announces new officers and changes to board
Rx-360 announces new officers and changes to board
The new officers will each serve a two-year term
Columbia Laboratories appoints Chief Medical Officer
Columbia Laboratories appoints Chief Medical Officer
Dr Bridget Martell takes up the newly created position
Mallinckrodt builds leadership team to support growth
Mallinckrodt builds leadership team to support growth
Gary Phillips and Hugh O’Neill take on new responsibilities
SP Industries appoints new Chief Operating Officer
SP Industries appoints new Chief Operating Officer
Brian Wright takes responsibility for factory operations, supply chain, logistics and facilities management
Catalent hires two General Managers
Catalent hires two General Managers
To oversee key clinical supply services facilities in the UK and Germany
Diapharm makes changes to senior management team
Diapharm makes changes to senior management team
Ralf Sibbing continues as General Manager while Martin Vortkamp leaves the company
Previous
1
…
120
121
122
123
(current)
124
125
126
…
216
Next
Trending Articles
New Managing Director for Shimadzu Europa
Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
BioDuro appoints Greg Makara to lead discovery chemistry
BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
EyeC expands OEM growth with new business development manager
Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
Three new commercial appointments for Symbiosis
Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
Lonza nominates Pearl Huang to board
Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation